 Laurel Lenz
Concepts (290)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Listeria monocytogenes | 28 | 2021 | 111 | 7.530 |
Why?
| | Listeriosis | 19 | 2021 | 60 | 5.420 |
Why?
| | Killer Cells, Natural | 12 | 2021 | 389 | 3.280 |
Why?
| | Interferon-gamma | 12 | 2019 | 749 | 2.500 |
Why?
| | Interleukin-10 | 5 | 2021 | 311 | 2.360 |
Why?
| | Receptors, Interferon | 8 | 2019 | 50 | 2.120 |
Why?
| | Myeloid Cells | 5 | 2020 | 128 | 2.070 |
Why?
| | Interferon Type I | 7 | 2019 | 131 | 1.690 |
Why?
| | Macrophages | 12 | 2020 | 1333 | 1.620 |
Why?
| | Interleukin-18 | 4 | 2018 | 231 | 1.320 |
Why?
| | Streptococcus pneumoniae | 2 | 2020 | 143 | 1.280 |
Why?
| | Dendritic Cells | 9 | 2018 | 445 | 1.180 |
Why?
| | Immunity, Innate | 12 | 2021 | 759 | 1.130 |
Why?
| | Bacterial Infections | 4 | 2018 | 238 | 1.050 |
Why?
| | Interferon-beta | 3 | 2018 | 87 | 1.040 |
Why?
| | Host-Pathogen Interactions | 3 | 2020 | 312 | 0.960 |
Why?
| | Mice, Inbred C57BL | 20 | 2021 | 5102 | 0.910 |
Why?
| | Bacterial Proteins | 7 | 2018 | 777 | 0.900 |
Why?
| | Interferon-alpha | 2 | 2018 | 193 | 0.890 |
Why?
| | Animals | 51 | 2022 | 34345 | 0.880 |
Why?
| | Mice | 40 | 2022 | 15984 | 0.860 |
Why?
| | Repressor Proteins | 2 | 2018 | 383 | 0.850 |
Why?
| | Mice, Knockout | 15 | 2021 | 2736 | 0.830 |
Why?
| | STAT3 Transcription Factor | 3 | 2022 | 192 | 0.810 |
Why?
| | Interleukin-15 | 2 | 2019 | 77 | 0.750 |
Why?
| | Casein Kinase II | 1 | 2020 | 21 | 0.740 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2020 | 41 | 0.680 |
Why?
| | Orthomyxoviridae Infections | 1 | 2020 | 56 | 0.670 |
Why?
| | N-Acetylmuramoyl-L-alanine Amidase | 3 | 2009 | 8 | 0.670 |
Why?
| | Influenza A virus | 1 | 2020 | 96 | 0.660 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2018 | 150 | 0.660 |
Why?
| | Bacteria | 3 | 2018 | 767 | 0.650 |
Why?
| | Lymphocyte Activation | 4 | 2016 | 1077 | 0.650 |
Why?
| | Pneumococcal Infections | 1 | 2020 | 97 | 0.650 |
Why?
| | Coinfection | 1 | 2020 | 123 | 0.640 |
Why?
| | Macrophage Activation | 4 | 2017 | 163 | 0.620 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2018 | 40 | 0.610 |
Why?
| | Streptococcal Infections | 1 | 2020 | 145 | 0.610 |
Why?
| | Disease Susceptibility | 4 | 2021 | 343 | 0.560 |
Why?
| | Leukocytes, Mononuclear | 1 | 2019 | 517 | 0.550 |
Why?
| | Flow Cytometry | 4 | 2016 | 1108 | 0.520 |
Why?
| | Pneumonia | 1 | 2021 | 610 | 0.510 |
Why?
| | Bacterial Vaccines | 2 | 2020 | 62 | 0.480 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 360 | 0.480 |
Why?
| | T-Lymphocytes, Cytotoxic | 6 | 2007 | 160 | 0.470 |
Why?
| | Influenza, Human | 1 | 2020 | 569 | 0.460 |
Why?
| | Early Growth Response Protein 3 | 1 | 2013 | 1 | 0.450 |
Why?
| | Lung Diseases | 1 | 2020 | 768 | 0.440 |
Why?
| | Interferon Regulatory Factor-3 | 3 | 2011 | 18 | 0.440 |
Why?
| | Antigens, Bacterial | 4 | 1998 | 121 | 0.430 |
Why?
| | Gene Silencing | 1 | 2013 | 181 | 0.420 |
Why?
| | Toll-Like Receptors | 3 | 2012 | 170 | 0.410 |
Why?
| | H-2 Antigens | 3 | 1997 | 111 | 0.410 |
Why?
| | Anthrax | 1 | 2012 | 9 | 0.410 |
Why?
| | Bacillus anthracis | 1 | 2012 | 11 | 0.410 |
Why?
| | Gene Expression | 3 | 2019 | 1528 | 0.400 |
Why?
| | Lymph Nodes | 2 | 2012 | 467 | 0.390 |
Why?
| | Lung | 3 | 2019 | 3865 | 0.390 |
Why?
| | Peptidoglycan | 2 | 2009 | 28 | 0.380 |
Why?
| | Cyclic GMP | 1 | 2011 | 111 | 0.380 |
Why?
| | Inflammasomes | 1 | 2012 | 120 | 0.380 |
Why?
| | Membrane Proteins | 4 | 2021 | 1089 | 0.360 |
Why?
| | Cyclic AMP | 1 | 2011 | 264 | 0.360 |
Why?
| | Interleukin-1beta | 1 | 2012 | 382 | 0.350 |
Why?
| | Cells, Cultured | 6 | 2019 | 4159 | 0.340 |
Why?
| | Recombinant Proteins | 3 | 2011 | 1327 | 0.340 |
Why?
| | Antigens | 1 | 2011 | 324 | 0.330 |
Why?
| | Down-Regulation | 5 | 2019 | 652 | 0.330 |
Why?
| | CD5 Antigens | 1 | 2009 | 8 | 0.330 |
Why?
| | Mice, Transgenic | 5 | 2021 | 2061 | 0.330 |
Why?
| | Intubation, Intratracheal | 1 | 2011 | 240 | 0.320 |
Why?
| | Bone Marrow Cells | 3 | 2010 | 276 | 0.310 |
Why?
| | Mice, Inbred BALB C | 8 | 2012 | 1233 | 0.310 |
Why?
| | Lymphocytes | 2 | 2014 | 356 | 0.310 |
Why?
| | Cell Communication | 1 | 2010 | 282 | 0.310 |
Why?
| | Recombination, Genetic | 1 | 2008 | 176 | 0.290 |
Why?
| | Genetic Vectors | 1 | 2008 | 315 | 0.280 |
Why?
| | Antigen Presentation | 3 | 1998 | 194 | 0.280 |
Why?
| | B-Lymphocytes | 1 | 2012 | 781 | 0.280 |
Why?
| | Nitric Oxide | 1 | 2012 | 886 | 0.280 |
Why?
| | Lipopolysaccharides | 3 | 2021 | 870 | 0.280 |
Why?
| | Adenosine Triphosphatases | 2 | 2007 | 162 | 0.270 |
Why?
| | Host-Parasite Interactions | 1 | 2007 | 112 | 0.270 |
Why?
| | Selection, Genetic | 1 | 2008 | 256 | 0.270 |
Why?
| | Head and Neck Neoplasms | 2 | 2021 | 482 | 0.270 |
Why?
| | Communicable Diseases | 1 | 2007 | 140 | 0.260 |
Why?
| | Female | 16 | 2021 | 64889 | 0.250 |
Why?
| | Inflammation | 3 | 2020 | 2612 | 0.240 |
Why?
| | Epitopes | 2 | 1997 | 450 | 0.240 |
Why?
| | Cytotoxicity, Immunologic | 3 | 2003 | 205 | 0.220 |
Why?
| | Coculture Techniques | 2 | 2016 | 211 | 0.210 |
Why?
| | Cytokines | 5 | 2020 | 1927 | 0.210 |
Why?
| | Cell Line | 5 | 2012 | 2806 | 0.210 |
Why?
| | Disease Models, Animal | 3 | 2020 | 3823 | 0.210 |
Why?
| | Membrane Transport Proteins | 1 | 2003 | 143 | 0.210 |
Why?
| | Escherichia coli Proteins | 1 | 2003 | 176 | 0.200 |
Why?
| | Radioimmunotherapy | 1 | 2021 | 12 | 0.200 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2016 | 837 | 0.190 |
Why?
| | Virulence | 3 | 2008 | 251 | 0.190 |
Why?
| | Ligands | 4 | 2019 | 574 | 0.190 |
Why?
| | Male | 10 | 2021 | 60792 | 0.190 |
Why?
| | Mouth Diseases | 1 | 2021 | 38 | 0.190 |
Why?
| | Vaccinia | 1 | 2000 | 19 | 0.180 |
Why?
| | Lymphocytic Choriomeningitis | 1 | 2000 | 12 | 0.180 |
Why?
| | Transcription, Genetic | 2 | 2019 | 1376 | 0.180 |
Why?
| | Humans | 19 | 2022 | 125131 | 0.180 |
Why?
| | Antigen-Presenting Cells | 1 | 2000 | 157 | 0.180 |
Why?
| | Legionnaires' Disease | 1 | 2019 | 5 | 0.170 |
Why?
| | Legionella pneumophila | 1 | 2019 | 3 | 0.170 |
Why?
| | Malaria, Cerebral | 1 | 2019 | 3 | 0.170 |
Why?
| | Bites and Stings | 1 | 2020 | 31 | 0.170 |
Why?
| | Signal Transduction | 6 | 2019 | 4809 | 0.170 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2022 | 216 | 0.160 |
Why?
| | CD4 Antigens | 1 | 2019 | 127 | 0.160 |
Why?
| | STAT4 Transcription Factor | 1 | 2018 | 4 | 0.160 |
Why?
| | Enhancer Elements, Genetic | 1 | 2019 | 163 | 0.160 |
Why?
| | Solubility | 1 | 2018 | 241 | 0.150 |
Why?
| | Disease Progression | 2 | 2022 | 2577 | 0.140 |
Why?
| | Interleukin-2 | 1 | 2018 | 424 | 0.140 |
Why?
| | Macrophages, Alveolar | 1 | 2019 | 363 | 0.140 |
Why?
| | Monocytes | 1 | 2019 | 523 | 0.140 |
Why?
| | Survival Analysis | 1 | 2019 | 1341 | 0.130 |
Why?
| | Amino Acid Sequence | 5 | 2009 | 2098 | 0.130 |
Why?
| | Chromatin | 1 | 2019 | 448 | 0.130 |
Why?
| | Adoptive Transfer | 1 | 2016 | 205 | 0.130 |
Why?
| | NF-kappa B | 1 | 2019 | 681 | 0.130 |
Why?
| | Adenocarcinoma | 1 | 2022 | 840 | 0.130 |
Why?
| | Phosphorylation | 2 | 2010 | 1694 | 0.120 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 286 | 0.120 |
Why?
| | Pancreatic Neoplasms | 1 | 2022 | 759 | 0.120 |
Why?
| | Breeding | 1 | 2014 | 58 | 0.120 |
Why?
| | Genotype | 1 | 2020 | 1960 | 0.120 |
Why?
| | Housing, Animal | 1 | 2014 | 46 | 0.120 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 84 | 0.110 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2013 | 138 | 0.110 |
Why?
| | T-Lymphocyte Subsets | 2 | 2007 | 406 | 0.110 |
Why?
| | Interleukin-12 | 3 | 2011 | 110 | 0.110 |
Why?
| | Caspases, Initiator | 1 | 2012 | 18 | 0.110 |
Why?
| | Reactive Oxygen Species | 2 | 2012 | 593 | 0.100 |
Why?
| | Spores, Bacterial | 1 | 2012 | 20 | 0.100 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 334 | 0.100 |
Why?
| | Receptors, CCR7 | 1 | 2012 | 25 | 0.100 |
Why?
| | Myeloid Differentiation Factor 88 | 2 | 2010 | 97 | 0.100 |
Why?
| | Phagosomes | 1 | 2012 | 43 | 0.100 |
Why?
| | Caspase 1 | 1 | 2012 | 143 | 0.100 |
Why?
| | Gastrointestinal Microbiome | 1 | 2018 | 557 | 0.100 |
Why?
| | Immunotherapy | 1 | 2016 | 499 | 0.100 |
Why?
| | Francisella tularensis | 1 | 2011 | 18 | 0.100 |
Why?
| | Lymphocyte Depletion | 1 | 2012 | 123 | 0.100 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2012 | 171 | 0.100 |
Why?
| | Receptors, Complement | 1 | 2012 | 115 | 0.100 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2012 | 102 | 0.100 |
Why?
| | Immunologic Factors | 1 | 2013 | 228 | 0.100 |
Why?
| | Instillation, Drug | 1 | 2011 | 8 | 0.100 |
Why?
| | Caspases | 1 | 2012 | 274 | 0.090 |
Why?
| | Vesiculovirus | 1 | 2011 | 10 | 0.090 |
Why?
| | Phagocytes | 1 | 2011 | 92 | 0.090 |
Why?
| | Adaptive Immunity | 1 | 2012 | 163 | 0.090 |
Why?
| | Cell Death | 1 | 2012 | 347 | 0.090 |
Why?
| | Immunoglobulin M | 1 | 2012 | 253 | 0.090 |
Why?
| | TRPM Cation Channels | 1 | 2011 | 72 | 0.090 |
Why?
| | Blotting, Western | 1 | 2013 | 1233 | 0.090 |
Why?
| | Immunologic Memory | 2 | 2007 | 322 | 0.090 |
Why?
| | STAT1 Transcription Factor | 1 | 2010 | 68 | 0.090 |
Why?
| | Histocompatibility Antigens Class I | 2 | 2003 | 176 | 0.090 |
Why?
| | Toll-Like Receptor 2 | 2 | 2007 | 130 | 0.080 |
Why?
| | Melanoma, Experimental | 1 | 2011 | 119 | 0.080 |
Why?
| | Infant | 2 | 2020 | 8625 | 0.080 |
Why?
| | Spleen | 2 | 2008 | 513 | 0.080 |
Why?
| | Gene Deletion | 2 | 2008 | 362 | 0.080 |
Why?
| | Receptors, Cell Surface | 2 | 2009 | 368 | 0.080 |
Why?
| | CD8-Positive T-Lymphocytes | 4 | 2008 | 717 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 1008 | 0.080 |
Why?
| | Immunotherapy, Adoptive | 1 | 2011 | 194 | 0.080 |
Why?
| | T-Lymphocytes, Regulatory | 2 | 2022 | 364 | 0.080 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2010 | 356 | 0.080 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2013 | 340 | 0.080 |
Why?
| | Alanine Racemase | 1 | 2008 | 2 | 0.080 |
Why?
| | Glutamate-Ammonia Ligase | 1 | 2008 | 9 | 0.080 |
Why?
| | Genetic Complementation Test | 1 | 2008 | 63 | 0.080 |
Why?
| | Tumor Microenvironment | 2 | 2021 | 463 | 0.080 |
Why?
| | AIDS Vaccines | 1 | 2008 | 44 | 0.080 |
Why?
| | Carrier Proteins | 1 | 2012 | 743 | 0.080 |
Why?
| | Liver | 3 | 2018 | 1872 | 0.080 |
Why?
| | Genes, Bacterial | 1 | 2008 | 163 | 0.080 |
Why?
| | Vaccines, Attenuated | 1 | 2008 | 114 | 0.080 |
Why?
| | Group IV Phospholipases A2 | 1 | 2007 | 45 | 0.070 |
Why?
| | Hemolysin Proteins | 1 | 2007 | 33 | 0.070 |
Why?
| | Macrophages, Peritoneal | 1 | 2007 | 97 | 0.070 |
Why?
| | Plasmids | 1 | 2008 | 361 | 0.070 |
Why?
| | Bacterial Toxins | 1 | 2007 | 107 | 0.070 |
Why?
| | Heat-Shock Proteins | 1 | 2007 | 129 | 0.070 |
Why?
| | Bystander Effect | 1 | 2007 | 15 | 0.070 |
Why?
| | Fungi | 1 | 2007 | 124 | 0.070 |
Why?
| | Biological Transport | 1 | 2007 | 392 | 0.070 |
Why?
| | Virulence Factors | 1 | 2007 | 142 | 0.070 |
Why?
| | Molecular Sequence Data | 4 | 2004 | 2926 | 0.070 |
Why?
| | Protein Structure, Tertiary | 1 | 2009 | 836 | 0.070 |
Why?
| | Autoantibodies | 1 | 2013 | 1382 | 0.070 |
Why?
| | Obesity | 1 | 2018 | 2805 | 0.060 |
Why?
| | Antibodies | 1 | 2007 | 396 | 0.060 |
Why?
| | Alleles | 2 | 2020 | 865 | 0.060 |
Why?
| | Antigens, CD1 | 1 | 2005 | 59 | 0.060 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2007 | 292 | 0.060 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2007 | 997 | 0.060 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2004 | 148 | 0.060 |
Why?
| | Autolysis | 1 | 2003 | 3 | 0.060 |
Why?
| | SEC Translocation Channels | 1 | 2003 | 10 | 0.060 |
Why?
| | Gene Expression Profiling | 1 | 2010 | 1642 | 0.060 |
Why?
| | Aged | 2 | 2020 | 20859 | 0.060 |
Why?
| | Interleukin-6 | 1 | 2007 | 710 | 0.050 |
Why?
| | Mutation | 3 | 2010 | 3520 | 0.050 |
Why?
| | T-Lymphocytes | 2 | 2007 | 1793 | 0.050 |
Why?
| | Neoplasms | 1 | 2016 | 2340 | 0.050 |
Why?
| | Nucleoproteins | 1 | 2000 | 28 | 0.050 |
Why?
| | Vaccinia virus | 1 | 2000 | 41 | 0.050 |
Why?
| | Lymphocytic choriomeningitis virus | 1 | 2000 | 20 | 0.050 |
Why?
| | Chimera | 1 | 2000 | 60 | 0.050 |
Why?
| | Cell Movement | 1 | 2005 | 913 | 0.050 |
Why?
| | Nucleotides, Cyclic | 1 | 2020 | 15 | 0.040 |
Why?
| | Base Sequence | 3 | 2004 | 2207 | 0.040 |
Why?
| | Gene Knock-In Techniques | 1 | 2020 | 47 | 0.040 |
Why?
| | Major Histocompatibility Complex | 1 | 2000 | 223 | 0.040 |
Why?
| | Germ-Free Life | 1 | 2018 | 30 | 0.040 |
Why?
| | Fatty Acids, Volatile | 1 | 2018 | 48 | 0.040 |
Why?
| | Diet, Western | 1 | 2018 | 70 | 0.040 |
Why?
| | Proteomics | 1 | 2003 | 903 | 0.040 |
Why?
| | Bile Acids and Salts | 1 | 2018 | 180 | 0.040 |
Why?
| | Dysbiosis | 1 | 2018 | 151 | 0.040 |
Why?
| | Transformation, Bacterial | 1 | 1996 | 5 | 0.030 |
Why?
| | Polymorphism, Genetic | 1 | 2020 | 669 | 0.030 |
Why?
| | Feces | 1 | 2018 | 402 | 0.030 |
Why?
| | Gene Library | 1 | 1996 | 130 | 0.030 |
Why?
| | Pregnancy | 2 | 2018 | 5922 | 0.030 |
Why?
| | Intestinal Mucosa | 1 | 2018 | 543 | 0.030 |
Why?
| | Adiposity | 1 | 2018 | 529 | 0.030 |
Why?
| | Rituximab | 1 | 2013 | 159 | 0.030 |
Why?
| | Parrots | 1 | 1992 | 1 | 0.030 |
Why?
| | Polyomaviridae | 1 | 1992 | 1 | 0.030 |
Why?
| | Guidelines as Topic | 1 | 2014 | 277 | 0.030 |
Why?
| | Bird Diseases | 1 | 1992 | 8 | 0.030 |
Why?
| | Mothers | 1 | 2018 | 740 | 0.030 |
Why?
| | Capsid | 1 | 1992 | 77 | 0.020 |
Why?
| | Papillomaviridae | 1 | 1992 | 104 | 0.020 |
Why?
| | Interleukin-12 Receptor beta 2 Subunit | 1 | 2011 | 2 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2007 | 1198 | 0.020 |
Why?
| | Disulfides | 1 | 2010 | 92 | 0.020 |
Why?
| | Dimerization | 1 | 2010 | 181 | 0.020 |
Why?
| | Body Weight | 1 | 2014 | 959 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2010 | 274 | 0.020 |
Why?
| | Adjuvants, Immunologic | 1 | 2011 | 211 | 0.020 |
Why?
| | Cancer Vaccines | 1 | 2011 | 141 | 0.020 |
Why?
| | Cysteine | 1 | 2010 | 188 | 0.020 |
Why?
| | Autoimmunity | 1 | 2014 | 835 | 0.020 |
Why?
| | Antibodies, Viral | 1 | 1992 | 561 | 0.020 |
Why?
| | Arachidonic Acids | 1 | 2007 | 58 | 0.020 |
Why?
| | Indomethacin | 1 | 2007 | 77 | 0.020 |
Why?
| | Mice, Inbred ICR | 1 | 2007 | 110 | 0.020 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2007 | 72 | 0.020 |
Why?
| | Cyclooxygenase 2 | 1 | 2007 | 171 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 168 | 0.020 |
Why?
| | Cytosol | 1 | 2007 | 232 | 0.020 |
Why?
| | MAP Kinase Signaling System | 1 | 2007 | 304 | 0.020 |
Why?
| | Calcium Signaling | 1 | 2007 | 223 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 1992 | 1300 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2007 | 863 | 0.020 |
Why?
| | Neutrophils | 1 | 2011 | 1250 | 0.020 |
Why?
| | Antigens, CD1d | 1 | 2005 | 65 | 0.020 |
Why?
| | Muromegalovirus | 1 | 2004 | 13 | 0.020 |
Why?
| | Mycobacterium bovis | 1 | 2004 | 18 | 0.020 |
Why?
| | Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2004 | 38 | 0.010 |
Why?
| | TNF-Related Apoptosis-Inducing Ligand | 1 | 2004 | 61 | 0.010 |
Why?
| | Interleukin-4 | 1 | 2005 | 211 | 0.010 |
Why?
| | Mast-Cell Sarcoma | 1 | 2003 | 4 | 0.010 |
Why?
| | Immunodominant Epitopes | 1 | 2003 | 27 | 0.010 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2004 | 202 | 0.010 |
Why?
| | Injections, Intravenous | 1 | 2003 | 219 | 0.010 |
Why?
| | Clone Cells | 1 | 2003 | 251 | 0.010 |
Why?
| | Sequence Deletion | 1 | 2003 | 178 | 0.010 |
Why?
| | Herpesviridae Infections | 1 | 2004 | 147 | 0.010 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2003 | 171 | 0.010 |
Why?
| | Membrane Glycoproteins | 1 | 2004 | 454 | 0.010 |
Why?
| | Calcium | 1 | 2007 | 1211 | 0.010 |
Why?
| | Mice, Inbred DBA | 1 | 1998 | 185 | 0.010 |
Why?
| | Phenotype | 1 | 2005 | 3153 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2003 | 2913 | 0.010 |
Why?
| | Time Factors | 1 | 2004 | 6780 | 0.010 |
Why?
| | Peptides | 1 | 1998 | 884 | 0.010 |
Why?
| | Chick Embryo | 1 | 1992 | 133 | 0.010 |
Why?
| | Hybridomas | 1 | 1992 | 233 | 0.010 |
Why?
|
|
Lenz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|